ARCHIVES

BCDDP “Major Accomplishment” Described By ACS’ Holleb

This article is from The Cancer Letter archive.

Vol. 04 No. 29 | July 21, 1978

Download PDF Visit The Full Archive

Related Articles

Bonadonna’s Study At Four Years: CMF Group Still Doing Better

November 24, 1978

Guest Editorial: Learning from the Power Morcellation Fiasco: Government Must Do More to Regulate Devices

September 12, 2014

NIH reiterates Position On Closed Meeting Of BSC Chairmen

September 23, 1994

Study of Dlurectic Use As Renal Cell Cancer Risk Gets Concept Approval

March 10, 1989

Treanda Approved For B-Cell Non-Hodgkin’s Lymphoma

October 31, 2008

In Brief: ACS Considers Expanding Psychosocial Program, Taylor Says; Mendelsohn, Pitot Join NTP Board

March 25, 1983